Fintel reports that on September 13, 2023, Truist Securities reiterated coverage of Salesforce (NYSE:CRM) with a Buy recommendation. Analyst Price Forecast Suggests 12.58% Upside
Fintel reports that on September 14, 2023, Wolfe Research initiated coverage of First Advantage (NASDAQ:FA) with a Outperform recommendation.
Fintel reports that on September 14, 2023, Cantor Fitzgerald reiterated coverage of Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Neutral recommendation.
Fintel reports that on September 13, 2023, Stifel reiterated coverage of Rocket Pharmaceuticals (NASDAQ:RCKT) with a Buy recommendation. Analyst Price Forecast Suggests 152.72% Upside
Fintel reports that on September 13, 2023, B of A Securities maintained coverage of Cisco Systems (NASDAQ:CSCO) with a Neutral recommendation. Analyst Price Forecast Suggests 3.68% Upside
Fintel reports that on September 14, 2023, HC Wainwright & Co. reiterated coverage of Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy recommendation.
Fintel reports that on September 13, 2023, Cantor Fitzgerald reiterated coverage of Connect Biopharma Holdings Ltd - ADR (NASDAQ:CNTB) with a Overweight recommendation.
Fintel reports that on September 13, 2023, Cantor Fitzgerald reiterated coverage of Editas Medicine (NASDAQ:EDIT) with a Overweight recommendation. Analyst Price Forecast Suggests 58.68% Upside
Fintel reports that on September 13, 2023, BMO Capital maintained coverage of Neurocrine Biosciences (NASDAQ:NBIX) with a Market Perform recommendation.
Fintel reports that on September 13, 2023, Cantor Fitzgerald reiterated coverage of Neurocrine Biosciences (NASDAQ:NBIX) with a Overweight recommendation.
Fintel reports that on September 13, 2023, HC Wainwright & Co. reiterated coverage of Neurocrine Biosciences (NASDAQ:NBIX) with a Buy recommendation.
Fintel reports that on September 13, 2023, Piper Sandler maintained coverage of Willis Towers Watson Public Limited (NASDAQ:WTW) with a Overweight recommendation.
Fintel reports that on September 13, 2023, Evercore ISI Group maintained coverage of Akero Therapeutics (NASDAQ:AKRO) with a Outperform recommendation.
Fintel reports that on September 13, 2023, Truist Securities reiterated coverage of Exelixis (NASDAQ:EXEL) with a Buy recommendation. Analyst Price Forecast Suggests 15.07% Upside
Fintel reports that on September 13, 2023, JP Morgan maintained coverage of Adobe (NASDAQ:ADBE) with a Neutral recommendation. Analyst Price Forecast Suggests 2.42% Upside
Fintel reports that on September 13, 2023, TD Cowen initiated coverage of Uranium Energy (AMEX:UEC) with a Speculative Buy recommendation.
Fintel reports that on September 13, 2023, Cantor Fitzgerald reiterated coverage of Beam Therapeutics (NASDAQ:BEAM) with a Overweight recommendation.